Results 251 to 260 of about 849,446 (392)

Understanding and addressing anti-drug antibody formation in tumor necrosis factor-α inhibitor therapy for ankylosing spondylitis. [PDF]

J Rheum Dis
Kim TJ.
europepmc   +1 more source

CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XIII. THE SEPARATION AND CONCENTRATION OF ISOHEMAGGLUTININS FROM GROUP-SPECIFIC HUMAN PLASMA 12 [PDF]

, 1944
Louis Pillemer, J. L. Oncley, M. Melin, John F. Elliott, M. C. Hutchinson   +4 more
openalex   +1 more source

The Potential for Extracellular Vesicles in Nanomedicine: A Review of Recent Advancements and Challenges Ahead

Advanced Biology, EarlyView.
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi, Anjali Kumari, Samaneh Ghadami, Saqer Al Abdullah, Kristen Dellinger   +4 more
wiley   +1 more source

Refractory pediatric actinic prurigo successfully treated with upadacitinib: A case report. [PDF]

SAGE Open Med Case Rep
Morissette F, Coulombe J.
europepmc   +1 more source

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

Proceedings of the National Academy of Sciences of the United States of America, 2008
F. Hodi, M. Butler, D. Oble, M. Seiden, M. Seiden, F. Haluska, A. Kruse, Suzanne Macrae, Marybeth Nelson, C. Canning, I. Lowy, A. Korman, D. Lautz, Sara E. Russell, M. Jaklitsch, N. Ramaiya, Teresa C Chen, D. Neuberg, J. Allison, M. Mihm, G. Dranoff   +20 more
semanticscholar   +1 more source

Inhibition of Glutamine Metabolism Attenuates Tumor Progression Through Remodeling of the Macrophage Immune Microenvironment

Advanced Biology, EarlyView.
The prodrug strategy used in this study offers new promise for cancer metabolism‐based therapies. JHU083, a prodrug that, when cleaved by protease in the tumor microenvironment, yields the glutamine antagonist DON. JHU083 inhibits tumor growth by targeting glutamine‐addicted cancer cells and suppressing glutamine‐dependent M2 macrophages, leading to a ...
Tianhe Li, Sepehr Akhtarkhavari, Sumeng Qi, Jiawei Fan, Tu‐Yung Chang, Yao‐An Shen, JinMing Yang, Barbara S. Slusher, Ie‐Ming Shih, Stephanie Gaillard, Tian‐Li Wang   +10 more
wiley   +1 more source

Immunology

The American Biology Teacher, 1993
openaire   +2 more sources

Oral Manifestations of Bullous Systemic Lupus Erythematosus: A Systematic Review. [PDF]

Acta Derm Venereol
Keller Goff G, Xu A.
europepmc   +1 more source

Studies on vaccinia haemagglutinin: II. Some immunological properties [PDF]

, 1948
Cordia Chu
openalex   +1 more source

Electric Pulse Regulated MXene Based Nanozymes for Integrative Bioelectricity Immuno‐Cancer Therapy

Advanced Functional Materials, EarlyView.
MXenzyme‐mediated bioelectricity cancer therapy (MXenzyme‐BECT) enhances cancer cell death through irreversible depolarization, ion channel disruption, ROS generation, and immunogenic cell death. Computational simulations reveal the electrical mechanisms by which MXenzyme acts on single cells and support to predict treatment parameters. Next‐generation
Sanghee Lee, Seongchan Kim, Eui‐Sang Yu, Sian Lee, Min Jun Ko, Hyojin Lee, Dong‐Hyun Kim   +6 more
wiley   +1 more source